Literature DB >> 11864667

Risk factors for difficult delivery in nulliparas with epidural analgesia in second stage of labor.

William D Fraser1, Mireille Cayer, Bettina M Soeder, Lucile Turcot, Sylvie Marcoux.   

Abstract

OBJECTIVE: To identify risk factors for difficult delivery among nulliparas in the second stage of labor with continuous epidural analgesia, and to develop a multivariable model that is predictive of difficult delivery.
METHODS: The database is derived from a multicenter randomized trial of delayed pushing for nulliparous women under continuous infusion epidural. Members of this cohort (n = 1862) were randomly divided into two groups: a "Model Development" and a "Model Validation" group. We used univariate and multivariable techniques to assess associations between anthropometric, sociodemographic, and obstetric variables and difficult delivery.
RESULTS: With the referent defined as the category of lesser risk, the developed model showed that the risk of difficult delivery was increased for women with height less than 160 cm (odds ratio [OR] 2.1, 90% confidence interval [CI] 1.2, 3.4), prepregnancy weight greater than 65 kg (OR 1.6, 90% CI 1.0, 2.6), age greater than or equal to 35 years (OR 3.0, 90% CI 1.1, 8.1), and gestational age greater than or equal to 41 weeks (OR 1.8, 90% CI 1.1, 2.8). Induction of epidural analgesia late in labor (greater than or equal to 6 cm) was associated with a higher risk of difficult delivery than induction between 3 and 5 cm (OR 1.9, 90% CI 1.3, 2.8). An interval of greater than or equal to 360 minutes between epidural induction and full dilatation increased the risk of difficult delivery (OR 3.8, 90% CI 1.5, 9.5). Fetal station above +2 at full dilatation and a posterior fetal position were both strongly associated with difficult delivery (OR 2.7, 90% CI 1.4, 5.0, and OR 11.2, 90% CI 4.9, 25.6, respectively). For the multivariable predictive model, when the sensitivity was 57%, the specificity was 75%, and the positive predictive value was 35%.
CONCLUSION: Our observations concerning maternal characteristics and obstetric variables are consistent with previous observations with the exception of time of induction of the epidural. The predictive model may be useful in defining high-risk populations for subsequent intervention studies designed to assess approaches to reduce difficult delivery.

Entities:  

Mesh:

Year:  2002        PMID: 11864667     DOI: 10.1016/s0029-7844(01)01755-0

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Alternative model of birth to reduce the risk of assisted vaginal delivery and perineal trauma.

Authors:  Carolina Walker; Tania Rodríguez; Ana Herranz; José A Espinosa; Emília Sánchez; Montserrat Espuña-Pons
Journal:  Int Urogynecol J       Date:  2012-02-02       Impact factor: 2.894

2.  Medical and nonmedical factors influencing utilization of delayed pushing in the second stage.

Authors:  Heather A Frey; Methodius G Tuuli; Sarah Cortez; Anthony O Odibo; Kimberly A Roehl; Anthony L Shanks; George A Macones; Alison G Cahill
Journal:  Am J Perinatol       Date:  2012-12-03       Impact factor: 1.862

3.  Obstetric risk indicators for labour dystocia in nulliparous women: a multi-centre cohort study.

Authors:  Hanne Kjaergaard; Jørn Olsen; Bent Ottesen; Per Nyberg; Anna-Karin Dykes
Journal:  BMC Pregnancy Childbirth       Date:  2008-10-06       Impact factor: 3.007

4.  Seasonal variation of dystocia in a large Danish cohort.

Authors:  Christine Rohr Thomsen; Niels Uldbjerg; Lone Hvidman; Hjördís Ósk Atladóttir; Tine Brink Henriksen; Ioanna Milidou
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

5.  The association between attendance of midwives and workload of midwives with the mode of birth: secondary analyses in the German healthcare system.

Authors:  Nina Knape; Herbert Mayer; Wilfried Schnepp; Friederike zu Sayn-Wittgenstein
Journal:  BMC Pregnancy Childbirth       Date:  2014-09-02       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.